Hytro Breaks New Ground with US Patent for Wearable BFR Tech

A major milestone for Hytro as it receives patent protection in the US, marking the next phase of global expansion.

In a significant leap forward for wearable Blood Flow Restriction (BFR) technology, Hytro has been officially granted a United States patent for its category-defining BFR wearables. The newly granted US Patent No. 12,317,940 protects Hytro’s unique design and integrated BFR mechanism until 2040, setting the foundation for accelerated growth in the US and reinforcing the brand’s leadership in performance and recovery innovation.

As the first and only wearable BFR product of its kind to be protected by a US patent, this moment marks a new chapter in Hytro’s mission to make the performance and recovery benefits of BFR accessible to athletes at every level.

“This is a deeply personal milestone for me,” said Dr. Warren Bradley, Founder and Head of Elite Performance at Hytro. “Back in 2018, I filed the original patent for Hytro, pouring all my life’s savings and all my belief into an idea I knew had the power to change how athletes train and recover. Now, 7 years later, to hold the granted US patent and welcome investment from world-class athletes who share that belief is incredible validation.
We’ve gone from a sketch on paper to a globally recognised product trusted by elite teams and now protected in the biggest market in the world. It’s been a long road, and this moment marks a major turning point.”

Powering Global Performance

Hytro is now trusted by over 250 elite teams globally, including powerhouses across the Premier League, Premiership Rugby, NFL, NBA, Formula 1, and leading athletes in sports such as boxing, athletics, tennis, and cycling.

From Manchester City Women’s FC and England Rugby to the Soudal Quick-Step Cycling Team, Hytro has become a go-to tool for performance staff looking to support athlete readiness, performance, and recovery, safely and efficiently.

As Hytro continues to gain traction across the US, working with NFL and MLB teams, elite athletes, and forward-thinking performance coaches, the patent unlocks a new level of opportunity. It validates not only the science behind the product but also the practical innovation that makes it so usable in real-world environments.

“This US patent is a huge moment for Hytro,” said Raj Thiruchelvarajah, CEO and Co-Founder of Hytro. “It validates the unique technology we’ve built from day one and protects the innovation that sets us apart in the market. We’ve grown rapidly from our UK roots, earning the trust of top teams across Europe, and now this gives us real momentum to expand further into the US. We’re committed to bringing the benefits of BFR to more athletes than ever before, and this milestone moves us one big step closer to that goal.”

A Simpler, Smarter BFR

At the heart of the patent is Hytro’s breakthrough method of safely embedding adjustable BFR into performance wear, eliminating the need for bulky straps or complex pneumatic systems that traditionally require expert supervision. The result is a product that gives athletes and coaches the ability to use BFR anytime, anywhere, safely and effectively.

The newly granted patent also supports Hytro’s ongoing commitment to research and innovation. As the brand expands its product range, deepens its collaborations with global teams, and partners with leading universities and research institutions, this moment represents more than just legal protection, it’s a signal of what’s still to come.

Hytro is currently raising investment to accelerate this next phase of growth. If you’re interested in learning more, please get in touch.